Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 222

1.

Cytokeratin profiles of male breast cancers.

Ciocca V, Bombonati A, Gatalica Z, Di Pasquale M, Milos A, Ruiz-Orrico A, Dreher D, Folch N, Monzon F, Santeusanio G, Perou CM, Bernard PS, Palazzo JP.

Histopathology. 2006 Oct;49(4):365-70.

PMID:
16978199
[PubMed - indexed for MEDLINE]
2.

Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.

Kusińska R, Potemski P, Jesionek-Kupnicka D, Kordek R.

Pol J Pathol. 2005;56(3):107-10.

PMID:
16334976
[PubMed - indexed for MEDLINE]
3.

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

Rakha EA, Putti TC, Abd El-Rehim DM, Paish C, Green AR, Powe DG, Lee AH, Robertson JF, Ellis IO.

J Pathol. 2006 Mar;208(4):495-506.

PMID:
16429394
[PubMed - indexed for MEDLINE]
4.

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.

Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G.

Hum Pathol. 2006 Sep;37(9):1217-26. Epub 2006 Jul 18.

PMID:
16938528
[PubMed - indexed for MEDLINE]
5.

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.

Fulford LG, Reis-Filho JS, Ryder K, Jones C, Gillett CE, Hanby A, Easton D, Lakhani SR.

Breast Cancer Res. 2007;9(1):R4.

PMID:
17217540
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.

Steinman S, Wang J, Bourne P, Yang Q, Tang P.

Ann Clin Lab Sci. 2007 Spring;37(2):127-34.

PMID:
17522367
[PubMed - indexed for MEDLINE]
7.

The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?

Fadare O, Wang SA, Hileeto D.

Hum Pathol. 2008 Mar;39(3):331-6. doi: 10.1016/j.humpath.2007.07.014.

PMID:
18261623
[PubMed - indexed for MEDLINE]
8.

p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer.

Ribeiro-Silva A, Ramalho LN, Garcia SB, Brandão DF, Chahud F, Zucoloto S.

Histopathology. 2005 Nov;47(5):458-66.

PMID:
16241993
[PubMed - indexed for MEDLINE]
9.

P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.

Paredes J, Lopes N, Milanezi F, Schmitt FC.

Virchows Arch. 2007 Jan;450(1):73-80. Epub 2006 Nov 23.

PMID:
17123107
[PubMed - indexed for MEDLINE]
10.

Basal cytokeratin expression in relation to immunohistochemical and clinical characterization in breast cancer patients with triple negative phenotype.

Liu ZB, Wu J, Ping B, Feng LQ, Di GH, Lu JS, Shen KW, Shen ZZ, Shaol ZM.

Tumori. 2009 Jan-Feb;95(1):53-62.

PMID:
19366057
[PubMed - indexed for MEDLINE]
11.

Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1.

Pintens S, Neven P, Drijkoningen M, Van Belle V, Moerman P, Christiaens MR, Smeets A, Wildiers H, Vanden Bempt I.

J Clin Pathol. 2009 Jul;62(7):624-8. doi: 10.1136/jcp.2008.061358.

PMID:
19561231
[PubMed - indexed for MEDLINE]
12.

Keratin expression in breast cancers.

Shao MM, Chan SK, Yu AM, Lam CC, Tsang JY, Lui PC, Law BK, Tan PH, Tse GM.

Virchows Arch. 2012 Sep;461(3):313-22. doi: 10.1007/s00428-012-1289-9. Epub 2012 Aug 1.

PMID:
22851038
[PubMed - indexed for MEDLINE]
13.

Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.

Dabbs DJ, Chivukula M, Carter G, Bhargava R.

Mod Pathol. 2006 Nov;19(11):1506-11. Epub 2006 Aug 25.

PMID:
16941011
[PubMed - indexed for MEDLINE]
Free Article
14.

Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa.

Awadelkarim KD, Arizzi C, Elamin EO, Hamad HM, De Blasio P, Mekki SO, Osman I, Biunno I, Elwali NE, Mariani-Costantini R, Barberis MC.

Histopathology. 2008 Mar;52(4):445-56. doi: 10.1111/j.1365-2559.2008.02966.x.

PMID:
18315597
[PubMed - indexed for MEDLINE]
15.

Prognostic relevance of basal cytokeratin expression in operable breast cancer.

Potemski P, Kusinska R, Watala C, Pluciennik E, Bednarek AK, Kordek R.

Oncology. 2005;69(6):478-85. Epub 2006 Jan 12.

PMID:
16410686
[PubMed - indexed for MEDLINE]
16.

Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray.

Williams DJ, Cohen C, To TV, Page AJ, Lawson D, Sussman ZM, Nassar A.

Hum Pathol. 2009 Aug;40(8):1176-81. doi: 10.1016/j.humpath.2009.01.003. Epub 2009 Apr 14.

PMID:
19368951
[PubMed - indexed for MEDLINE]
17.

Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors.

Laakso M, Loman N, Borg A, Isola J.

Mod Pathol. 2005 Oct;18(10):1321-8.

PMID:
15990899
[PubMed - indexed for MEDLINE]
Free Article
18.

Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.

Celis JE, Gromova I, Cabezón T, Gromov P, Shen T, Timmermans-Wielenga V, Rank F, Moreira JM.

Mol Oncol. 2007 Dec;1(3):321-49. doi: 10.1016/j.molonc.2007.09.004. Epub 2007 Sep 25.

PMID:
19383306
[PubMed - indexed for MEDLINE]
Free Article
19.

Prognostic markers in triple-negative breast cancer.

Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO.

Cancer. 2007 Jan 1;109(1):25-32.

PMID:
17146782
[PubMed - indexed for MEDLINE]
Free Article
20.

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast.

Fulford LG, Easton DF, Reis-Filho JS, Sofronis A, Gillett CE, Lakhani SR, Hanby A.

Histopathology. 2006 Jul;49(1):22-34.

PMID:
16842243
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk